Institutional Review Board

CONSENT DOCUMENT TEMPLATES


Informed Consent is a process by which a subject voluntarily confirms his or her willingness to participate in a particular study, after having been informed of all aspects of the study that are relevant to the subject’s decision to participate.  The method of obtaining and documenting informed consent must be outlined in the study protocol and approved by the LSUHSC-NO IRB. Please refer to the Guidance on Informed Consent for additional information. 

Template ID Template Title About the Template Version #
Standard Consent Form Templates
HRP-2250 LSUHSC Joint Consent/HIPAA Template Complete Instructions 3.2
HRP-2251 LSUHSC Joint Consent/HIPAA Template Minimal Instructions 3.2
HRP-2251 LSUHSC-UMC Joint Consent/HIPAA Template Use when UMC is a performance site 3.2
HRP-2251 LSUHSC-OLOL Joint Consent/HIPAA Template Use when OLOL is a performance site 3.2
  LSUHSC-CHNOLA Joint Consent Form Use when Children's Hospital is a performance site  
Short Consent Form Templates
HRP-2252 Short Consent Form - English Example Form Only 1.0
HRP-2253 Short Consent Form - French Use when unexpectedly enrolling a French-speaking subject (max of 2 uses) 1.0
HRP-2254 Short Consent Form - Spanish Use when unexpectedly enrolling a Spanish-speaking subject (max of 2 uses) 1.0
HRP-2254C CHNOLA-LSUHSC Short Consent Form - Spanish Use when unexpectedly enrolling a Spanish-speaking subject at Children's Hospital 1.0
HRP-2255 Short Consent Form - Vietnamese Use when unexpectedly enrolling a Vietnamese-speaking subject (max of 2 uses) 1.0
Expanded Access and Humanitarian Use Device Consent Templates
HRP-2257 Emergency Use of a Test Article Consent Template Use when emergently treating a patient with an unapproved drug or device  1.2
HRP-2257C CHNOLA-LSUHSC EUTA Consent Template Use when emergently treating a patient at Children's Hospital with an unapproved drug or device 1.0
HRP-2257 Non-Emergency Use of a Test Article Consent Template Use when non-emergently treating a patient with an unapproved drug or device 1.1
HRP-2258 HUD Treatment Consent Template Use when treating a patient with a Humanitarian Use Device  1.5
Other Consent Templates
HRP-2259 Exempt Research Information Sheet Use when Waiver of Documentation of Informed Consent is granted for Exempt research  1.2
HRP-2260 Case Report Consent Template Use when accessing a patient chart to write a case report (optional) 1.1
HRP-2261 Biorepository Consent Template Use when enrolling a subject in an optional biorepository arm of a study 1.1
HRP-2262 Pregnant Partner Consent Template Use when the study requires monitoring of a subject's pregnant partner 1.2
HRP-2267 Healthy Volunteer Consent Template Use when enrolling healthy volunteers  3.2
Verbal Consent Templates
HRP-2263 Verbal Informed Consent Template Use when Permission for Verbal Consent is granted by the IRB 1.2
HRP-2264 Verbal Consenting Script Template Use when Permission for Verbal Consent is granted by the IRB (optional) 1.1
Assent Templates
HRP-2265 Assent Template - Ages 7-12 Use when enrolling children ages 7-12 in a study not occurring at Children's Hospital 1.1
HRP-2266 Assent Template - Ages 13-17 Use when enrolling children ages 13-17 in a study not occurring at Children's Hospital 1.1
Informed Consent Cover Letters
  LSUHSC ICF Cover Letter Template Attach to the front of a consent packet when using a non-HSC consent template   
  CHNOLA-LSUHSC ICF Cover Letter Template Attach to the front of a consent packet when using a non-HSC consent template to enroll subjects at Children's Hospital   

 

Translation of Study Documents

Certified translations are required for studies that intend to enroll non-English-speaking individuals. The investigator is responsible for the cost of translating study materials. Please include the associated certificate(s) of translation upon submission of the translated document(s) to the IRB. To learn more about what qualifies as a certified translation please review the ATA website (Certification – American Translators Association (ATA) (atanet.org).

Translation Companies (Note: The IRB does not endorse any translation service)

The “short form” method for obtaining informed consent should only be used for the occasional and unexpected enrollment of a non-English-speaking participant. If the study design includes intent to enroll non-English-speaking individuals, or once the study team encounters one unexpected participant speaking a non-English language, the Informed Consent Form must be fully translated to that language.

Use of Sponsor Consent Forms Templates                                                                                                                                                                      

LSUHSC prefers use of our local-approved template; however, if the study team wishes to use the Sponsor template, the LSUHSC ICF Cover Letter must be provided along with the Sponsor consent, or the required language must be embedded into the form. If the designated reviewer does not feel that the Sponsor template contains all the appropriate information or that the quality is poor, the reviewer reserves the right to request the team switch to use of the local-approved template.